Kfar Saba, Israel
Dr. Shai Yarkoni co-founded our subsidiary, Cellect Biotherapeutics, in 2011, and has served as our
Chief Executive Officer and a director since 2013 and of our subsidiary since inception. Dr. Yarkoni has over
15 years of clinical and management experience in the biopharmaceutical industry. Dr. Yarkoni is a founder of
Sne, an Israeli technology transfer company established in 2013. Since 1999, Dr. Yarkoni has also been the
Chief Executive Officer and Chairman of GASR Biotechnology, a life sciences consulting and investing firm.
From 2009 until 2013, Dr. Yarkoni served as Chief Executive Officer of BioNegev, an international innovation
center for biotechnology and life sciences in the Negev region. Prior to that he served as Chief Executive
Officer of Target-In Ltd., a developer of therapeutic recombinant proteins for cancer treatment and as Chief
Technology Officer and Vice President R&D of Collgard Biopharmaceutical, a tissue therapeutics company,
and was an attending OB/GYN specialist practicing for approximately thirteen years. Dr. Yarkoni holds an
M.D and Ph.D from the Hadassah Medical School, Jerusalem, Israel, and is a board certified OB/GYN.
Dr. Yarkoni is the author of over 60 scientific papers and inventor of approximately 20 patents.